10TH INTERNATIONAL CONGRESS OF HUMAN GENETICS

Laura Sarantaus (Poster Presentation)

    Activity: Participating in or organising an event typesOrganisation and participation in conferences, workshops, courses, seminars

    Description

    BRCA1 and BRCA2 founder mutations account for 5% of 233 unselected Finnish ovarian carcinoma patients
    Period15 May 200119 May 2001
    Event typeOther
    LocationVienna, Austria
    Degree of RecognitionInternational